title: Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
authors.affiliation: Instituto de Urologia e Nefrologia, São Jośe do Rio Preto, São Paulo, Brazil.
authors.forename: M
authors.initials: M
authors.lastname: Abbud-Filho
authors.forename: J B
authors.initials: JB
authors.lastname: Barberato
authors.forename: H J
authors.initials: HJ
authors.lastname: Ramalho
authors.forename: L B
authors.initials: LB
authors.lastname: Saldanha
authors.forename: D M
authors.initials: DM
authors.lastname: Casassanta
authors.forename: E R
authors.initials: ER
authors.lastname: Denadai
authors.forename: S
authors.initials: S
authors.lastname: Zerati
authors.forename: A G
authors.initials: AG
authors.lastname: Bezas
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D011188:Potassium / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use*
chemical_list: D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine; D011188:Potassium; D011241:Prednisone